Evidence map›Paper›PMID 41152208›Full record

ReviewPhotodermatology, photoimmunology & photomedicine2025

PINGing Sunshine: A Review of the Evidence for Adding Non-Filtering Photoprotective Ingredients to Sunscreens.

Jean Krutmann, Anthony Brown, Thierry Passeron, Corinne Granger, Yolanda Gilaberte, Carles Trullas, Jaime Piquero-Casals, Giovanni Leone, Sergio Schalka, Henry W Lim

Abstract readReview
In one paragraph

Review in Photodermatology, photoimmunology & photomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jean KrutmannIUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.ORCID https://orcid.org/0000-0001-8433-1517
Anthony BrownInnovation and Development, ISDIN, Barcelona, Spain.ORCID https://orcid.org/0000-0002-1271-310X
Thierry PasseronDepartment of Dermatology, Centre Hospitalier Universitaire de Nice, Côte D'azur University, Nice, France.ORCID https://orcid.org/0000-0002-0797-6570
Corinne GrangerStella Polaris Europe SAS, Paris, France.ORCID https://orcid.org/0000-0001-5117-448X
Yolanda GilaberteMiguel Servet University Hospital, University of Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0001-8034-3617
Carles TrullasInnovation and Development, ISDIN, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1925-5102
Jaime Piquero-CasalsDermik Clinica Dermatologica Multidisciplinar, Barcelona, Spain.ORCID https://orcid.org/0000-0002-4481-5602
Giovanni LeonePhotodermatology Unit, Israelite Hospital, Roma, Italy.ORCID https://orcid.org/0000-0001-6120-2712
Sergio SchalkaMedcin Skin Research Center and Biochemistry Department, Chemistry Institute of São Paulo University, São Paulo, Brazil.ORCID https://orcid.org/0000-0003-2425-7962
Henry W LimDepartment of Dermatology, Henry Ford Health, Detroit, Michigan, USA.ORCID https://orcid.org/0000-0002-1576-1115

Funding

ISDIN
6 · The paper itself

Abstract

backgroundPhotoprotective INGredients (PINGs) are non-filtering agents that enhance the skin's intrinsic defenses against solar radiation. Acting through antioxidant, DNA repair, immunomodulatory, anti-inflammatory, and pigmentation-regulating mechanisms, PINGs may prevent or repair photodamage. When incorporated into sunscreens, they offer protection beyond ultraviolet (UV) filters. This strategy of biological photoprotection could address key limitations of traditional sunscreens and reduce dependence on high UV filter concentrations.

methodsWe conducted a focused literature review based on our prior evidence-based classification of over 1700 topical PINGs. We selected ingredients with the strongest clinical and mechanistic support and assessed their biological activity, formulation compatibility, and relevance to key endpoints such as erythema, pigmentation, photoaging, and immunosuppression.

resultsTop-ranked PINGs, including L-ascorbic acid, tocopherol, photolyase, and nicotinamide, demonstrated efficacy across multiple photodamage endpoints. Antioxidants like L-ascorbic acid and tocopherol enhanced protection against UVR and IR-A-induced oxidative stress. DNA repair enzymes, such as photolyase, reduced cyclobutane pyrimidine dimer formation and supported immune function. Nicotinamide improved DNA repair and prevented UV-induced immunosuppression. Pigmentation modulators such as p-coumaric acid and isobutylamido thiazolyl resorcinol showed benefits in darker phototypes.

conclusionsFewer than 2% of candidate PINGs are clinically validated, and only 18 are approved for use in sunscreens. Protection against visible and infrared radiation remains largely underexplored. Standardized testing and additional clinical trials are needed to advance PINGs as effective components of next-generation sunscreens.

Indexed as

AntioxidantsSkin AgingSunscreening AgentsUltraviolet RaysDNA RepairHumansAntioxidantsSunscreening AgentsantioxidantsDNA repairinfrared and visible light protectionnicotinamidenon‐filtering ingredientsoxidative stressphotolyasephotoprotectionskin photoagingsunscreens

Identifiers

PMID41152208
PMCPMC12568756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.